ClearGuard HD caps are simple to use, highly effective and are the first and only device for sale designed to kill infection-causing bacteria inside a hemodialysis catheter hub. Designed to kill microorganisms, not intended to be used for treatment of existing infections.
Clinically proven to reduce the rate of CLABSIs in hemodialysis catheter patients
Multiple large, prospective, cluster-randomized multicenter open-label trials demonstrated a significant reduction in the rate of positive blood cultures (PBCs) and CLABSIs using ClearGuard HD caps vs. control groups.
Catheter infections are frequent, costly, and deadly
- Catheters cause 70% of vascular access-related BSIs, and central venous catheters are used in only 19% of all dialysis procedures in the United States.
- Central line-associated bloodstream infections (CLABSIs) are a leading cause of hospitalizations and the second leading cause of death in hemodialysis patients.
- CLABSIs are very expensive, with an estimated increase in healthcare costs of approximately $27,232-$68,983, with an average of $48,108 per infection.
Reduce hemodialysis catheter infections with a simple, intuitive design
The ClearGuard HD cap features a rod that extends into the hemodialysis catheter hub. The rod and cap threads are coated with chlorhexidine, a well-known broad-spectrum antimicrobial agent.
- When the ClearGuard HD cap is inserted into a liquid-filled catheter, chlorhexidine elutes from the rod into the catheter lock solution.
- The chlorhexidine coating dissolves to kill microorganisms on the inside and outside of the catheter hub.
- The existing catheter clamp holds the antimicrobial agent inside the catheter hub between treatments.
- ClearGuard HD caps are used in place of a standard cap or connector.
- Designed to meet your needs, ClearGuard HD caps can be used with heparin, citrate, and saline solutions.